Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,774 | 69,751 | 84,456 | 79,898 | 118,031 |
| Marketable Securities | 224,099 | 238,234 | 292,163 | 303,987 | 318,552 |
| Receivables | 40,347 | 46,238 | 32,972 | 24,504 | 15,529 |
| Inventories | 12,417 | 10,212 | 9,826 | 7,718 | 5,216 |
| TOTAL | $356,320 | $380,465 | $435,111 | $431,324 | $471,798 |
| Non-Current Assets | |||||
| PPE Net | 19,250 | 19,680 | 19,336 | 18,205 | 18,263 |
| Investments And Advances | 94,783 | 158,123 | 127,084 | 145,437 | 145,569 |
| Other Non-Current Assets | 35,003 | 29,008 | 27,347 | 22,365 | 21,202 |
| TOTAL | $149,036 | $206,811 | $173,767 | $186,007 | $185,034 |
| Total Assets | $505,356 | $587,276 | $608,878 | $617,331 | $656,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,929 | 12,248 | 9,654 | 7,889 | 7,011 |
| Accrued Expenses | 65,639 | 86,012 | 59,733 | 45,653 | 56,273 |
| TOTAL | $82,268 | $99,990 | $70,613 | $54,500 | $68,917 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 0 | N/A | 4,652 |
| Other Non-Current Liabilities | 5,693 | 6,182 | 5,684 | 6,101 | 5,581 |
| TOTAL | $5,693 | $6,182 | $5,684 | $6,101 | $20,475 |
| Total Liabilities | $87,961 | $106,172 | $76,297 | $60,601 | $89,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,323 | 74,936 | 74,386 | 74,273 | 74,086 |
| Common Shares | 8 | 7 | 7 | 7 | 7 |
| Retained earnings | -1,236,352 | -1,153,165 | -1,075,868 | -1,022,338 | -982,419 |
| Other shareholders' equity | -6 | 725 | 1,551 | -77 | 249 |
| TOTAL | $417,395 | $481,104 | $532,581 | $556,730 | $567,440 |
| Total Liabilities And Equity | $505,356 | $587,276 | $608,878 | $617,331 | $656,832 |